|Articles|June 1, 1999

June 1999 - Special Issue
Volume 5
Issue 1 SP

Implementing Effectiveness Research and Improving Care for Schizophrenia in Real-World Settings

Author(s)Peter F. Buckley, MD, Alexander Miller, MD, John A. Chiles, MD

Download PDF: Implementing Effectiveness Research and Improving Care for Schizophrenia in Real-World Settings

Articles in this issue

about 27 years ago

Article

The State of Behavioral Health in Managed Care

about 27 years ago

Article

A Framework for Assessing the Effectiveness, Efficiency, and Equity of Behavioral Healthcare

about 27 years ago

Article

New Directions in Alcohol and Drug Treatment Under Managed Care

about 27 years ago

Article

Managed Public Mental Healthcare: Issues, Trends, and Prospects

about 27 years ago

Article

Use of Performance Standards in Behavioral Health Carve-Out Contracts Among Fortune 500 Firms

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Implementing Effectiveness Research and Improving Care for Schizophrenia in Real-World Settings

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

Switch to Ocrelizumab Shows Safety in Patients With Relapsing MS

ATTR-CM Incidence, Prevalence Rose Sharply in the US

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Implementing Effectiveness Research and Improving Care for Schizophrenia in Real-World Settings

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

Switch to Ocrelizumab Shows Safety in Patients With Relapsing MS

ATTR-CM Incidence, Prevalence Rose Sharply in the US